A new study has found the prevalence of multiple sclerosis rose by a third between 2006 and 2022. The University of Auckland study used Stats NZ data and included anonymous data from hospitalisations, ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Cyclists rolled along the scenic roads of Chilliwack and Abbotsford on the weekend to raise money for multiple sclerosis.

The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year ...

Columnist Ben Hofmeister reveals how MS heat sensitivity now hinders his ability to fully enjoy summer activities.

Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Researchers from Mātai Medical Research Institute in Gisborne are helping develop a new MRI scan method, which they say can ...